Efficient repair of cyclobutane pyrimidine dimers at mutational hot spots is restored in complemented xeroderma pigmentosum group C and trichothiodystrophy/xeroderma pigmentosum group D cells

Journal of Molecular Biology

Volumn 332, Issue 2, 2003, Pages 337-351

  Zhou, Ning Ye ^a   Bates, Steven E ^a   Bouziane, Mohammed ^a   Stary, Anne ^b   Sarasin, Alain ^b   O'Connor, Timothy R ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UPR 2169 CNRS   (France)

Author keywords

DNA repair; Ligation mediated PCR; Nucleotide excision repair; Xeroderma pigmentosum

Indexed keywords

COMPLEMENTARY DNA; CYCLOBUTANE DERIVATIVE; NUCLEOTIDE; PROTEIN P53; PYRIMIDINE DIMER; RETROVIRUS VECTOR;

ARTICLE; CELL LINE; CONTROLLED STUDY; DATA BASE; DNA REPAIR; EVALUATION; FIBROBLAST; GENE MUTATION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SYMPTOM; TRICHOTHIODYSTROPHY; ULTRAVIOLET C RADIATION; XERODERMA PIGMENTOSUM;

EID: 0041507114     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00793-9     Document Type: Article

References (63)

1. de Boer J., Hoeijmakers J.H. Nucleotide excision repair and human syndromes. Carcinogenesis. 21:2000;453-460.
2. Friedberg E.C. How nucleotide excision repair protects against cancer. Nature Rev. Cancer. 1:2001;22-33.
3. Cleaver J.E. Defective repair replication of DNA in Xeroderma pigmentosum. Nature. 218:1968;652-656.
4. Cleaver J.E. Xeroderma pigmentosum: a human disease in which an initial stage of DNA repair is defective. Proc. Natl Acad. Sci. USA. 63:1969;428-435.
5. Cleaver J.E. DNA damage and repair in light-sensitive human skin disease. J. Invest. Dermatol. 54:1970;181-195.
6. Cleaver J.E., Trosko J.E. Absence of excision of ultraviolet-induced cyclobutane dimers in xeroderma pigmentosum. Photochem. Photobiol. 11:1970;547-550.
7. Carreau M., Quilliet X., Eveno E., Salvetti A., Danos O., Heard J.M., et al. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients. Hum. Gene. Ther. 6:1995;1307-1315.
8. Cleaver J.E., Bootsma D., Friedberg E. Human diseases with genetically altered DNA repair processes. Genetics. 79:1975;215-225.
9. Giannelli F. Complementation in vitro between fibroblasts from normal subjects and patients with xeroderma pigmentosum. Clin. Sci. 40:1971;27.
10. Kraemer K.H., De Weerd-Kastelein E.A., Robbins J.H., Keijzer W., Barrett S.F., Petinga R.A., Bootsma D. Five complementation groups in xeroderma pigmentosum. Mutat. Res. 33:1975;327-340.
11. Sancar A. DNA excision repair. Annu. Rev. Biochem. 65:1996;43-81.
12. Wood R.D. DNA repair in eukaryotes. Annu. Rev. Biochem. 65:1996;135-167.
13. Wood R.D. Nucleotide excision repair in mammalian cells. J. Biol. Chem. 272:1997;23465-23468.
14. Itin P.H., Sarasin A., Pittelkow M.R. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J. Am. Acad. Dermatol. 44:2001;891-920.
15. Eveno E., Bourre F., Quilliet X., Chevallier-Lagente O., Roza L., Eker A.P., et al. Different removal of ultraviolet photoproducts in genetically related xeroderma pigmentosum and trichothiodystrophy diseases. Cancer Res. 55:1995;4325-4332.
16. Araki M., Masutani C., Takemura M., Uchida A., Sugasawa K., Kondoh J., et al. Centrosome protein centrin 2/caltractin 1 is part of the xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair. J. Biol. Chem. 276:2001;18665-18672.
17. Sugasawa K., Masutani C., Uchida A., Maekawa T., van der Spek P.J., Bootsma D., et al. HHR23B, a human Rad23 homolog, stimulates XPC protein in nucleotide excision repair in vitro. Mol. Cell. Biol. 16:1996;4852-4861.
18. Sugasawa K., Ng J.M., Masutani C., Iwai S., van der Spek P.J., Eker A.P., et al. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol. Cell. 2:1998;223-232.
19. Yokoi M., Masutani C., Maekawa T., Sugasawa K., Ohkuma Y., Hanaoka F. The xeroderma pigmentosum group C protein complex XPC-HR23B plays an important role in the recruitment of transcription factor IIH to damaged DNA. J. Biol. Chem. 275:2000;9870-9875.
20. Schaeffer L., Moncollin V., Roy R., Staub A., Mezzina M., Sarasin A., et al. The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor. EMBO J. 13:1994;2388-2392.
21. Sung P., Bailly V., Weber C., Thompson L.H., Prakash L., Prakash S. Human xeroderma pigmentosum group D gene encodes a DNA helicase. Nature. 365:1993;852-855.
22. Keriel A., Stary A., Sarasin A., Rochette-Egly C., Egly J.M. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha. Cell. 109:2002;125-135.
23. Ellison A.R., Nouspikel T., Jaspers N.G., Clarkson S.G., Gruenert D.C. Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome. Expt. Cell Res. 243:1998;22-28.
24. Gozukara E.M., Parris C.N., Weber C.A., Salazar E.P., Seidman M.M., Watkins J.F., et al. The human DNA repair gene, ERCC2 (XPD), corrects ultraviolet hypersensitivity and ultraviolet hypermutability of a shuttle vector replicated in xeroderma pigmentosum group D cells. Cancer Res. 54:1994;3837-3844.
25. Muotri A.R., Marchetto M.C., Suzuki M.F., Okazaki K., Lotfi C.F., Brumatti G., et al. Low amounts of the DNA repair XPA protein are sufficient to recover UV-resistance. Carcinogenesis. 23:2002;1039-1046.
26. Quilliet X., Chevallier-Lagente O., Eveno E., Stojkovic T., Destee A., Sarasin A., Mezzina M. Long-term complementation of DNA repair deficient human primary fibroblasts by retroviral transduction of the XPD gene. Mutat. Res. 364:1996;161-169.
27. Quilliet X., Chevallier-Lagente O., Zeng L., Calvayrac R., Mezzina M., Sarasin A., Vuillaume M. Retroviral-mediated correction of DNA repair defect in xeroderma pigmentosum cells is associated with recovery of catalase activity. Mutat. Res. 385:1997;235-242.
28. Zeng L., Quilliet X., Chevallier-Lagente O., Eveno E., Sarasin A., Mezzina M. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C. Gene Ther. 4:1997;1077-1084.
29. Zeng L., Sarasin A., Mezzina M. Retrovirus-DNA mediated repair gene transfer into xeroderma pigmentosum cells: perspectives for a gene therapy. Cell Biol. Toxicol. 14:1998;105-110.
30. Marionnet C., Quilliet X., Benoit A., Armier J., Sarasin A., Stary A. Recovery of normal DNA repair and mutagenesis in trichothiodystrophy cells after transduction of the XPD human gene. Cancer Res. 56:1996;5450-5456.
31. Kinzler K.W., Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature. 386:1997;761-763.
32. Pfeifer G.P. Formation and processing of UV photoproducts: effects of DNA sequence and chromatin environment. Photochem. Photobiol. 65:1997;270-283.
33. Sage E. Distribution and repair of photolesions in DNA: genetic consequences and the role of sequence context. Photochem. Photobiol. 57:1993;163-174.
34. Yoon J.H., Lee C.S., O'Connor T.R., Yasui A., Pfeifer G.P. The DNA damage spectrum produced by simulated sunlight. J. Mol. Biol. 299:2000;681-693.
35. You Y.H., Lee D.H., Yoon J.H., Nakajima S., Yasui A., Pfeifer G.P. Cyclobutane pyrimidine dimers are responsible for the vast majority of mutations induced by UVB irradiation in mammalian cells. J. Biol. Chem. 276:2001;44688-44694.
36. Giglia-Mari G., Sarasin A. TP53 mutations in human skin cancers. Hum. Mutat. 21:2003;217-228.
37. Hainaut P., Hollstein M. p53 and human cancer: the first ten thousand mutations. Advan. Cancer Res. 77:2000;81-137.
38. Pfeifer G.P., Denissenko M.F. Formation and repair of DNA lesions in the p53 gene: relation to cancer mutations? Environ. Mol. Mutagen. 31:1998;197-205.
39. Denissenko M.F., Pao A., Tang M., Pfeifer G.P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science. 274:1996;430-432.
40. Drouin R., Therrien J.P. UVB-induced cyclobutane pyrimidine dimer frequency correlates with skin cancer mutational hotspots in p53. Photochem. Photobiol. 66:1997;719-726.
41. Hainaut P., Olivier M., Pfeifer G.P. TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database. Mutagenesis. 16:2001;551-553. See also pp. 555-556.
42. Tommasi S., Denissenko M.F., Pfeifer G.P. Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases. Cancer Res. 57:1997;4727-4730.
43. Therrien J.P., Drouin R., Baril C., Drobetsky E.A. Human cells compromised for p53 function exhibit defective global and transcription-coupled nucleotide excision repair, whereas cells compromised for pRb function are defective only in global repair. Proc. Natl Acad. Sci. USA. 96:1999;15038-15043.
44. Pfeifer G.P., Denissenko M.F., Tang M.S. PCR-based approaches to adduct analysis. Toxicol. Letters. 102-103:1998;447-451.
45. Tornaletti S., Pfeifer G.P. Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science. 263:1994;1436-1438.
46. Tornaletti S., Rozek D., Pfeifer G.P. The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer. Oncogene. 8:1993;2051-2057.
47. Gao S., Drouin R., Holmquist G.P. DNA repair rates mapped along the human PGK1 gene at nucleotide resolution. Science. 263:1994;1438-1440.
48. Dai S.M., O'Connor T.R., Holmquist G.P., Riggs A.D., Flanagan S.D. Ligation-mediated PCR: robotic liquid handling for DNA damage and repair. Biotechniques. 33:2002;1090-1097.
49. O'Connor T.R., Chen H.-H., Dai S.-M., Flanagan S.D., Akman S.A., Holmquist G.P., et al. (2003). Mapping Oxidative DNA Damage at Nucleotide Resolution in Mammalian Cells In Oxidative Stress and Aging: Advances in Basic Science, Diagnostics, and Intervention (Cutler R. G., & Rodriguez, H., eds) vol. 1, pp. 257-274, World Scientific Publishing Company, River Edge, NJ USA.
50. Ford J.M., Hanawalt P.C. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl Acad. Sci. USA. 92:1995;8876-8880.
51. Ford J.M., Hanawalt P.C. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J. Biol. Chem. 272:1997;28073-28080.
52. Lloyd D.R., Hanawalt P.C. p53-dependent global genomic repair of benzo[a]pyrene-7,8-diol-9,10-epoxide adducts in human cells. Cancer Res. 60:2000;517-521.
53. Lloyd D.R., Hanawalt P.C. p53 controls global nucleotide excision repair of low levels of structurally diverse benzo(g)chrysene-DNA adducts in human fibroblasts. Cancer Res. 62:2002;5288-5294.
54. Smith M.L., Ford J.M., Hollander M.C., Bortnick R.A., Amundson S.A., Seo Y.R., et al. p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol. Cell. Biol. 20:2000;3705-3714.
55. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
56. Counter C.M., Hahn W.C., Wei W., Caddle S.D., Beijersbergen R.L., Lansdorp P.M., et al. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl Acad. Sci. USA. 95:1998;14723-14728.
57. Ouellette M.M., McDaniel L.D., Wright W.E., Shay J.W., Schultz R.A. The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes. Hum. Mol. Genet. 9:2000;403-411.
58. Ye N., Holmquist G.P., O'Connor T.R. Heterogeneous repair of N-methylpurines at the nucleotide level in normal human cells. J. Mol. Biol. 284:1998;269-285.
59. Marionnet C., Benoit A., Benhamou S., Sarasin A., Stary A. Characteristics of UV-induced mutation spectra in human XP-D/ERCC2 gene-mutated xeroderma pigmentosum and trichothiodystrophy cells. J. Mol. Biol. 252:1995;550-562.
60. Pfeifer G.P., Drouin R., Riggs A.D., Holmquist G.P. Binding of transcription factors creates hot spots for UV photoproducts in vivo. Mol. Cell. Biol. 12:1992;1798-1804.
61. Dai S.M., Chen H.H., Chang C., Riggs A.D., Flanagan S.D. Ligation-mediated PCR for quantitative in vivo footprinting. Nature Biotechnol. 18:2000;1108-1111.
62. Broughton B.C., Berneburg M., Fawcett H., Taylor E.M., Arlett C.F., Nardo T., et al. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene. Hum. Mol. Genet. 10:2001;2539-2547.
63. Pfeifer G.P., Holmquist G.P. Mutagenesis in the P53 gene. Biochim. Biophys. Acta. 1333:1997;M1-M8.